WallStSmart

Corteva Inc (CTVA)vsSherwin-Williams Co (SHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sherwin-Williams Co generates 34% more annual revenue ($23.94B vs $17.89B). SHW leads profitability with a 10.9% profit margin vs 6.5%. CTVA appears more attractively valued with a PEG of 1.31. CTVA earns a higher WallStSmart Score of 64/100 (C+).

CTVA

Buy

64

out of 100

Grade: C+

Growth: 4.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 1.49

SHW

Buy

56

out of 100

Grade: C

Growth: 5.3Profit: 7.5Value: 5.3Quality: 4.0
Piotroski: 4/9Altman Z: 1.54
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVASignificantly Overvalued (-68.0%)

Margin of Safety

-68.0%

Fair Value

$44.32

Current Price

$77.46

$33.14 premium

UndervaluedFair: $44.32Overvalued
SHWUndervalued (+4.8%)

Margin of Safety

+4.8%

Fair Value

$320.70

Current Price

$300.09

$20.61 discount

UndervaluedFair: $320.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 8.5/10
Market CapQuality
$51.88B9/10

Large-cap with strong market position

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

SHW2 strengths · Avg: 9.5/10
Return on EquityProfitability
58.7%10/10

Every $100 of equity generates 59 in profit

Market CapQuality
$73.12B9/10

Large-cap with strong market position

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.8%3/10

ROE of 4.8% — below average capital efficiency

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

P/E RatioValuation
41.9x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-2.97B2/10

Negative free cash flow — burning cash

SHW4 concerns · Avg: 4.0/10
PEG RatioValuation
2.294/10

Expensive relative to growth rate

P/E RatioValuation
28.5x4/10

Moderate valuation

Price/BookValuation
16.6x4/10

Trading at 16.6x book value

Altman Z-ScoreHealth
1.544/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Market Cap, Debt/Equity, Price/Book. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.31 suggests the stock is reasonably priced for its growth.

Bull Case : SHW

The strongest argument for SHW centers on Return on Equity, Market Cap.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 41.9x leaves little room for execution misses.

Bear Case : SHW

The primary concerns for SHW are PEG Ratio, P/E Ratio, Price/Book. Debt-to-equity of 3.11 is elevated, increasing financial risk.

Key Dynamics to Monitor

SHW carries more volatility with a beta of 1.16 — expect wider price swings.

CTVA is growing revenue faster at 11.0% — sustainability is the question.

SHW generates stronger free cash flow (800,000), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CTVA scores higher overall (64/100 vs 56/100) and 11.0% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Sherwin-Williams Co

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Sherwin Williams Company is a Cleveland, Ohio based company in the paint and coating manufacturing industry. The company primarily engages in the manufacture, distribution, and sale of paints, coatings, floorcoverings, and related products to professional, industrial, commercial, and retail customers primarily in North and South America and Europe.

Want to dig deeper into these stocks?